ZIM Corporation operates in the biomedical and emerging technology companies. It focuses on developing intellectual property, and research and development in the areas of new synthetic drugs and Immunotherapies. The company also offers spherical metal powders for additive manufacturing; and develops novel biomaterial for regenerative medicine. ZIM Corporation was founded in 1997 and is headquartered in Ottawa, Canada.